Concepedia

Publication | Open Access

COVID‐19 in patients with myasthenia gravis: Epidemiology and disease course

46

Citations

7

References

2021

Year

Abstract

The risk of COVID-19 in MG patients seems to be no higher than that of the general population, regardless of immunosuppressive therapies. In our cohort, COVID-19 barely affected MG course.

References

YearCitations

Page 1